Skip to product information
1 of 1

Pacific Blue Mouse Anti-Human CD206 Antibody (S-R575)

Pacific Blue Mouse Anti-Human CD206 Antibody (S-R575)

Catalog Number: S0B8343 Application: FCM Reactivity: Human Conjugation: Pacific Blue Brand: Starter
Price:
Regular price $150 USD
Regular price Sale price $150 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen CD206
Synonyms Macrophage mannose receptor 1; MMR; C-type lectin domain family 13 member D; C-type lectin domain family 13 member D-like; Human mannose receptor (hMR); Macrophage mannose receptor 1-like protein 1; CLEC13D; CLEC13DL; MRC1L1; MRC1
Location Endosome, Cell membrane
Accession P22897
Clone Number S-R575
Antibody Type Mouse mAb
Isotype IgG1,k
Application FCM
Reactivity Hu
Positive Sample GM-CSF and IL-4 treated Human peripheral blood mononuclear cells
Purification Protein G
Concentration 0.2 mg/ml
Conjugation Pacific Blue
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.3% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 5μl per million cells in 100μl volume Hu

Background

CD206, also known as the mannose receptor (MRC1), is a highly glycosylated type I transmembrane protein primarily expressed on the surface of macrophages and dendritic cells. It plays a crucial role in the innate immune response by mediating the endocytosis and phagocytosis of various pathogens, including bacteria, fungi, and viruses, through its ability to bind to mannan-coated cell walls or envelopes. CD206 is a marker for alternatively activated M2 macrophages, which are characterized by their anti-inflammatory phenotype and are involved in wound healing and immune tolerance. In the context of cancer, tumor-associated macrophages often exhibit high levels of CD206, contributing to tumor progression by promoting immunosuppression, metastasis, and angiogenesis. This makes CD206 a potential target for cancer immunotherapy, as its activation can enhance both adaptive and innate antitumor immune responses.

Picture

FC

Flow cytometric analysis of Human CD206 expression on GM-CSF and IL-4 stimulated monocytes. Human peripheral blood mononuclear cells were untreated (Left panel) or cultured for 3 days with 2 μg/ml Recombinant Human GM-CSF and 50 ng/ml Recombinant Human IL-4 (Right panel), then stained with SDT Pacific Blue Mouse Anti-Human CD206 Antibody at 5 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.